Western blot analysis clearly demonstrated a reduction in TRP53 protein levels in Eμ-Myc/dCas9a-SAMKI/+/sgMdm2 lymphomas compared to control lymphoma cells, consistent with elevated MDM2 levels (Supplementary Fig. 6b). This evidence concerns the gene TP53 and lymphoma.